O’Hara-based KaliVir awarded federal funding for cutting-edge cancer research

An O’Hara-based biotechnology company is getting a boost from the federal government to advance its cutting-edge cancer treatment research. KaliVir, situated along Alpha Drive in the RIDC Park, was founded in 2019 and designs oncolytic virus immunotherapies. The treatment uses genetically modified viruses to infect and destroy cancer cells while,